Posts by CaretakerAdmin

Among the many benefits being brought to the healthcare service by wireless patient monitoring is the facility to escalate home care for both chronic and acute conditions. Physicians have long recognized the benefits of care at home but hospitals have been reluctant to send acute patients home because it would have impacted on their revenue…

As new variants of the COVID-19 virus continue to pile pressure on already strained health services around the world, what hope is there for the future of medicine? With an ageing global population and a growing shortage of medical professionals, how can the healthcare industry get on top of the burgeoning workload to create breathing…

Wireless monitors like VitalStream™ can help to drive down the cost of chronic disease management and deliver better patient outcomes. Chronic disease management (CDM) is one of biggest challenges facing global health. Chronic conditions such as heart disease and diabetes are the leading cause of mortality in the developed world by far, and across the…

Medical practitioners know that even a brief hypotensive event can harm a patient. This is why the ICU employs continuous hemodynamic monitoring to catch the earliest signs of such events and enable prompt intervention. However, studies have found that post-operative patients returning to the general ward are still at risk of acute hypotensive events leading…

MedTech Innovator, the largest accelerator of medical devices in the world, announced that Caretaker Medical have been selected among five finalists out of 1,100 applicants to compete for the title of MedTech Innovator 2021. “Every year I am more impressed by the caliber of companies that take part in our Accelerator and Showcase programs,” said…

We are excited to announce the U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform.

Background Contract Research Organizations (CROs) like Celerion conduct drug research studies on behalf of pharmaceutical companies, using cohorts of healthy subjects, who are paid for their participation. A study can last for anything from one day to two months, sometimes longer, and during the trial, subjects’ vital signs are monitored. This can involve collections of…